P53-mediated apoptosis requires inositol hexakisphosphate kinase-2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 49, 2010, Pages 20947-20951

  Koldobskiy, Michael A ^a   Chakraborty, Anutosh ^a   Werner Jr , J Kent ^a   Snowman, Adele M ^a   Juluri, Krishna R ^a   Vandiver, M Scott ^a   Kim, Seyun ^a   Heletz, Shira ^a   Snyder, Solomon H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL HEXAKISPHOSPHATE KINASE 2; PROTEIN KINASE; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CONTROLLED STUDY; ENZYME ANALYSIS; GENE DISRUPTION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; HUMANS; PHOSPHOTRANSFERASES (PHOSPHATE GROUP ACCEPTOR); PROTEIN BINDING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78649955044     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1015671107     Document Type: Article

References (38)

1. Irvine RF, SchellMJ (2001) Back in the water: The return of the inositol phosphates. Nat Rev Mol Cell Biol 2:327-338.
2. Luo HR, et al. (2003) Inositol pyrophosphates mediate chemotaxis in Dictyostelium via pleckstrin homology domain-PtdIns(3,4,5)P3 interactions. Cell 114:559-572.
3. Saiardi A, Resnick AC, Snowman AM,Wendland B, Snyder SH (2005) Inositol pyrophosphates regulate cell death and telomere length through phosphoinositide 3-kinaserelated protein kinases. Proc Natl Acad Sci USA 102:1911-1914.
4. York SJ, Armbruster BN, Greenwell P, Petes TD, York JD (2005) Inositol diphosphate signaling regulates telomere length. J Biol Chem 280:4264-4269.
5. Saiardi A, Sciambi C, McCaffery JM, Wendland B, Snyder SH (2002) Inositol pyrophosphates regulate endocytic trafficking. Proc Natl Acad Sci USA 99:14206-14211.
6. Illies C, et al. (2007) Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells. Science 318:1299-1302.
7. Morrison BH, Bauer JA, Kalvakolanu DV, Lindner DJ (2001) Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells. J Biol Chem 276:24965-24970.
8. Nagata E, et al. (2005) Inositol hexakisphosphate kinase-2, a physiologic mediator of cell death. J Biol Chem 280:1634-1640.
9. Shears SB (2007) Understanding the biological significance of diphosphoinositol polyphosphates ('inositol pyrophosphates'). Biochem Soc Symp 74:211-221.
10. Mulugu S, et al. (2007) A conserved family of enzymes that phosphorylate inositol hexakisphosphate. Science 316:106-109.
11. Lee YS, Mulugu S, York JD, O'Shea EK (2007) Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates. Science 316:109-112.
12. Bhandari R, Juluri KR, Resnick AC, Snyder SH (2008) Gene deletion of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation of insulin secretion, growth, and spermiogenesis. Proc Natl Acad Sci USA 105:2349-2353.
13. Morrison BH, et al. (2002) Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics. Oncogene 21:1882-1889.
14. Chakraborty A, et al. (2008) HSP90 regulates cell survival via inositol hexakisphosphate kinase-2. Proc Natl Acad Sci USA 105:1134-1139.
15. Morrison BH, et al. (2009) Gene deletion of inositol hexakisphosphate kinase 2 predisposes to aerodigestive tract carcinoma. Oncogene 28:2383-2392.
16. Bunz F, et al. (1999) Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 104:263-269.
17. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B (2000) Role of BAX in the apoptotic response to anticancer agents. Science 290:989-992.
18. Nakano K, Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7:683-694.
19. Villunger A, et al. (2003) p53- and drug-induced apoptotic responses mediated by BH3- only proteins puma and noxa. Science 302:1036-1038.
20. Waldman T, Kinzler KW, Vogelstein B (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55:5187-5190.
21. Jänicke RU, Sohn D, Essmann F, Schulze-Osthoff K (2007) The multiple battles fought by anti-apoptotic p21. Cell Cycle 6:407-413.
22. Bunz F, et al. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282:1497-1501.
23. Kruse JP, Gu W (2009) Modes of p53 regulation. Cell 137:609-622.
24. Ofek P, Ben-Meir D, Kariv-Inbal Z, Oren M, Lavi S (2003) Cell cycle regulation and p53 activation by protein phosphatase 2C alpha. J Biol Chem 278:14299-14305.
25. Morrison BH, Tang Z, Jacobs BS, Bauer JA, Lindner DJ (2005) Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-beta-induced apoptosis in ovarian carcinoma. Biochem J 385:595-603.
26. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L (2003) PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 100:1931-1936.
27. Seoane J, Le HV, Massague J (2002) Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419:729-734.
28. Vousden KH, Prives C (2009) Blinded by the light: The growing complexity of p53. Cell 137:413-431.
29. Samuels-Lev Y, et al. (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 8:781-794.
30. Das S, et al. (2007) Hzf determines cell survival upon genotoxic stress by modulating p53 transactivation. Cell 130:624-637.
31. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849.
32. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
33. Gatz SA, Wiesmuller L (2006) p53 in recombination and repair. Cell Death Differ 13:1003-1016.
34. Jeffers JR, et al. (2003) Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4:321-328.
35. Shibue T, et al. (2003) Integral role of Noxa in p53-mediated apoptotic response. Genes Dev 17:2233-2238.
36. Jacobs WB, Kaplan DR, Miller FD (2006) The p53 family in nervous system development and disease. J Neurochem 97:1571-1584.
37. Bae BI, et al. (2005) p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47:29-41.
38. Saiardi A, Erdjument-Bromage H, Snowman AM, Tempst P, Snyder SH (1999) Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases. Curr Biol 9:1323-1326.